There is one month left to advance techniques for the surveillance and detection of adverse events associated with FDA products in the precisionFDA Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data Challenge. Final submissions are due on May 18th. A new discussion is now available on the challenge site with additional submission guidelines, tips, and tricks!

If you have any questions about the challenge, please feel free to post them in this thread, and we will respond as quickly as possible.

Thank you again for your continued support!